首页> 外国专利> Method for treating colorectal cancer, composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinotecan (FOLFIRI), article of manufacture, Kit

Method for treating colorectal cancer, composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinotecan (FOLFIRI), article of manufacture, Kit

机译:治疗结肠直肠癌的方法,包含阿柏西普,亚叶酸,5-氟尿嘧啶(5-fu)和伊立替康(FOLFIRI)的组合物,制品,试剂盒

摘要

A Pharmaceutical composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinotecan (FOLFIRI) useful for the treatment of Colorectal Cancer (CRC).Claim 1: a method to treat colorectal cancer (CRC) or a symptom of Colorectal Cancer (CRC) in a patient in need, Said method comprising administering to said patient therapeutically effective amounts of aflibercept, folinic acid, 5-fluorouracil (5-fu) And irinotecan.Claim 24: a composition comprising therapeutically effective amounts of aflibercept in combination with folinic acid, 5-fluorouracil (5-fu) and irinotecan for Patients with CRC in the Administrations of aflibercept, folinic acid,5-fluorouracil (5-fu) and irinotecan are Spaced along a period of time to obtain the maximum efficiency of the combination.
机译:药物组合物,其包含阿柏西普,亚叶酸,5-氟尿嘧啶(5-fu)和伊立替康(FOLFIRI),可用于治疗结直肠癌(CRC)。权利要求1:一种治疗结直肠癌(CRC)或结直肠症状的方法所述方法包括向所述患者施用治疗有效量的阿非西普,亚叶酸,5-氟尿嘧啶(5-fu)和伊立替康。权利要求24:一种组合物,其包含治疗有效量的阿非西普与亚氟酸,5-氟尿嘧啶(5-fu)和伊立替康一起用于阿柏西普治疗中的CRC患者,将亚叶酸,5-氟尿嘧啶(5-fu)和伊立替康在一段时间内隔开,以最大程度地提高这个组合。

著录项

  • 公开/公告号AR086051A1

    专利类型

  • 公开/公告日2013-11-13

    原文格式PDF

  • 申请/专利权人 SANOFI;

    申请/专利号AR2012P101420

  • 发明设计人 CASTAN REMI;

    申请日2012-04-25

  • 分类号A61K38;A61K31/4745;A61K31/513;A61P35;

  • 国家 AR

  • 入库时间 2022-08-21 15:58:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号